Corneal biomechanics and corneal ectasia, especially keratoconus (KC), are closely linked. In previous ex vivo studies using stress-strain measurements, corneas affected by KC exhibited reduced biomechanical behavior, as evidenced by lower stress and modulus of elasticity.
1,2 KC is a progressive disease with increasing steepening of the corneal curvature, decreasing corneal thickness, and changes in the distribution of corneal epithelial thickness,
3 with thinning of the epithelium that occurs over the cone, which is surrounded by a thicker epithelial ring. Corneal cross-linking (CXL) has become the gold standard for the treatment of KC, which aims to increase the strength of the cornea through a photo-oxidative process using riboflavin and ultraviolet light type A.
4–6 In addition to numerous experimental studies,
7 these effects have also been demonstrated in vivo using Scheimpflug based air-puff tonometry, with the so-called dynamic corneal response (DCR) parameters (Corvis ST; Oculus Optikgeraete GmbH, Wetzlar, Germany) proving sensitive enough to detect such biomechanical changes after CXL, especially 1 month after treatment.
8–11 A recent study confirmed the long-term efficacy of the treatment over a 15-year period.
12 In addition, a randomized controlled trial confirmed the clinical need that led to US Food and Drug Administration (FDA) approval.
13 This study also showed that only 25% of treated patients had a significant improvement in visual acuity (gain of more than 2 lines). Consequently, there are a number of patients who benefit from treatment in terms of corneal stability but not visual acuity. Therefore, there is a need for improvement in the visual acuity of patients with KC, especially if they are intolerant to rigid gas permeable or scleral lenses. Kanellopoulos and Asimellis were the first who showed that combining CXL with excimer laser ablation (“Athens protocol”) can improve vision, with laser ablation being performed first and CXL immediately afterwards.
14 They showed a significant increase in both best corrected and uncorrected visual acuity.
14–16 However, this study also reported a reduction in corneal tissue of 80 µm. To overcome this potential problem, Gore et al. published a protocol aiming to correct only ocular wavefront aberrations using a transepithelial photorefractive keratectomy (tPRK) combined with immediate CXL, without the primary goal to reduce the sphere and cylinder of refraction.
17 The protocol saves tissue and could be applied to mild and moderate KC with good visual results. However, the removal of tissue and thus the reduction of corneal thickness by laser correction stands in contradiction with the disease itself, as KC has a biomechanically weakened cornea. The aim of this study was to demonstrate in vivo that the combination of corneal wavefront-guided tPRK with CXL is not inferior to epithelium-off (epi-off) accelerated CXL in terms of biomechanical outcome 1 month after the treatment.